Related Experiment Video
Updated: May 16, 2026
09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
Channel blocking of MspA revisited
Ayomi S Perera1, Hongwang Wang, Matthew T Basel
1Department of Chemistry, Kansas State University, Manhattan, Kansas 66506, United States. ayomee@ksu.edu
Langmuir : the ACS Journal of Surfaces and Colloids
|December 11, 2012
Summary
Ruthenium(II)quaterpyridinium complexes effectively block Mycobacterium smegmatis Porin A (MspA) channels. This discovery advances potential new treatments for tuberculosis by understanding MspA channel blocker interactions.
Area of Science:
- Biophysics
- Materials Science
- Microbiology
Background:
- Mycobacterium smegmatis Porin A (MspA) is a key electrolyte transporter in mycobacteria.
- MspA's narrow, negatively charged constriction zone facilitates analyte binding and channel blockage.
- Targeting MspA is crucial for developing novel tuberculosis therapeutics.
Purpose of the Study:
- To investigate the potential of ruthenium(II)quaterpyridinium complexes as MspA channel blockers.
- To elucidate the interaction mechanisms between RuC2 complex and MspA.
- To explore the formation of RuC2@MspA assemblies.
Main Methods:
- High-performance liquid chromatography (HPLC) and steady-state luminescence studies.
- Time-resolved absorption/emission spectroscopy.
- Atomic force microscopy (AFM), dynamic light scattering (DLS), ζ potential measurements, and isothermal titration calorimetry (ITC).
Main Results:
- Ruthenium(II) complexes demonstrated high binding constants with MspA.
- Evidence of RuC2 and MspA forming clusters and large aggregates (RuC2@MspA).
- Characterization of MspA-channel blocker interactions using multiple biophysical techniques.
Conclusions:
- Ruthenium(II)quaterpyridinium complexes are effective MspA channel blockers.
- The study provides insights into the chemical nature of MspA-channel blocker interactions.
- Findings contribute to developing a paradigm for porin channel blocking strategies.
Related Concept Videos
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
02:19The Spindle Assembly Checkpoint
The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:32Postsynaptic Potential (PSP)
Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...